1Cera K R, Mahan D C, Reinhart G A. Weekly digestibility of diets supplemented with maize oil, lard or tallow by weanling swine[J]. Journal Animal Science, 1988, 66:1430-1437.
2Cera K R, Mahan D C, Reinhart G A. Evaluation of various extracted vegetable oil, roasted soybeans, medlum-chaln triglyeeride and an animal-vegetable fat blend for postweaning swine[J]. Journal of Animal Science, 1990,68: 2756-2765.
3Russett C. Lecithin and early weaned pigs [M]. Specialty Product Reports From Research. LEC-S-29. Central Soya Company Inc. 2002.
4Li D F, Thaler R C, Nelssen J L, et al.Effects of fat sources and combinations on starter pig performances, nutrient digestibility and intestinal morphology [J]. Journal of Animal Science. 1990,68: 3694-3704.
5Gu X, Li D, Fat nutrition and metabolism in piglets: a review[J]. Animal Feed Science and Technology, 2003,109:151-170.
6Li Y D, Peisker M. Soybean lecithin in Animal Nutrition[J]. Feed Magazine. 2005,(1-2). 28-34.
7Mountzourisl K C, Fegeros K, Papadopoulos G. Utilization of fats based on the composition of sow milk fat in the diet of weanling pigs[J]. Animal Feed Science and Technology, 1999,77 : 115-124.
8Doppenherg J, van der Aar P J. A review of the feeding value of fats and oils in feeds for swine and poultry [M]. Facts about fats. Schothorst Feed Rresearch,2010, 33-48.
9Jensen J S, Jensen S K, Jakobsen K. Development of digestive enzymes in pigs with emphasis on lipolytic activity in the storn ach and pancreas[J]. Journal of Animal Science, 1997,75: 437 -445.
10穆玉云.磷脂的营养功能及其在动物生产中的应用.中国畜牧杂志,2010,:32-39.
二级参考文献26
1Yarosh D, Klein J, Kibitel J. Enzyme therapy of xeroderma pigmentosum:safety and efficacy testing of T4N5 liposome lotion containing a prokaryotic DNA repair enzyme[J ] .Photodermatol Photoimmunol Photomed, 1996,12(3) : 122.
2J acobs M,Martin GP,Mariott C.Effect of phosphtidyl cholide on the topical bioavailability of corticostoroids assessed by the human skin blanching assay[J].J Pharm Parmacol,1988,40:829.
3Plessis J, Ramaehandran C, Weiner N, et al. Liposomes as a topical drug delivery system[J ]. Int J Pharm, 1996,127(2) : 273.
4Touitou E, Levi - Schaffer F, Dayan, et al. Modulation of caffeine skin delivery by carrier design..liposomes versus permeation enhancers[J] . Int J Pharm, 1994, 103:131.
5Bonina FP, Montenegro L, Scrofani N, et al. Effects of phospholipid bassed formulations on in vitro and in vivo percutaneous absorption of methyl ncotinate[J] .J Controlled Release, 1995, 34: 53.
6Ceve G, Gabiele B, Andreas S, et al. The skinia pathway for systemic treatment with patches and lipid based agent carries[J ] .Advanced Durg Delivery Reviews, 1996,18:349.
7Cevc G, Schatzlein A, Blume G. Transdermal drug carriers: basic properties, potlmlzation and transfer- efficiency in the case of epicutaneonsly applied pepides[J ].J Control Release, 1995, 36( 1- 2) : 3.
8Cevc G, Gebauer D, Stieber J, et al. Ultraflexible vesicles, transfersomes, have an extremely low pore penetration resistance and transport therapeutic amouts of insulin across the intact mammalian skin [J ]. Biochem Biophys Acta. 1998, 1368(2) :201.
9Hofer C, Hartung R, Gobel R, et al. New ultradeformable drug carriers for potential transdermal application of interleuki -2 and interferon-alpha: theoretic and practical aspects[J ]. World J Surg, 2000, 24(10) : 1 187.
10Hofer C, Gobel R, Deering P, et al. Formulation of interleuki - 2 and interferon - alpha containing ultradeformable carriers for potential transdermal application[ J] .Anticancer Res, 1999, 19(2c) : 1 505.
